-
Nightingale Health to publish half-year report for July – December 2022 on 23 March 2023 – Mar 15, 2023
-
Strategic collaboration in Estonia progresses: Nightingale Health completes the analysis of 200,000 Estonian Biobank samples – Mar 08, 2023
-
Nightingale Health combines genetics with its unique blood test results in Livit by Nightingale Health service – Feb 03, 2023
-
Nightingale Health to open laboratory in the United Kingdom in 2023 – Jan 25, 2023
-
Independent study: Nightingale Health’s blood test shown to enhance health check-ups by predicting many diseases at once – Oct 07, 2022
-
Nightingale Health to publish Financial Statements Release for financial year July 2021–June 2022 on 29 September 2022 – Sep 23, 2022
-
Further landmark evidence released to showcase the ability of Nightingale Health’s technology to predict hundreds of diseases from a single blood sample – Jun 14, 2022
-
Nightingale Health partners with Physitrack, expanding the availability of its preventative wellbeing service Livit to Germany, the UK and in the Nordics – Jun 08, 2022
-
Analysis: Nightingale Health’s net impact among the top 7 percent of companies worldwide – May 31, 2022
-
Nightingale Health launches consumer service Livit by Nightingale Health utilizing its at-home testing solution – Mar 31, 2022
-
Nightingale to publish half-year report for July – December 2021 on 24 February 2022 – Feb 16, 2022
-
Nightingale’s information security management certification continued with outstanding results in surveillance audit – Jan 20, 2022
-
Nightingale Home service launched with major Finnish pharmacy chain Yliopiston Apteekki – Dec 22, 2021
-
Nightingale’s preventative health service launched at Shin-Oyama City Hospital in Japan – Dec 21, 2021
-
Nightingale expands its Japan laboratory – Dec 17, 2021
-
Nightingale’s corporate health service piloted at Mitsui headquarters in Tokyo – Nov 18, 2021
-
Nightingale launches Nightingale Home and Nightingale Pro service models – Nov 15, 2021
-
Recording of event: An hour with Nightingale – Oct 28, 2021
-
Nightingale and BioBank Japan to realise personalised medicine and preventative health in Japan – Oct 28, 2021
-
Invitation to event: An hour with Nightingale – Oct 18, 2021
-
Fimea inspected Nightingale’s regulatory compliance with the requirements for manufacturer of medical device – Oct 14, 2021
-
Nightingale receives CE marking for its at-home blood collection kit – Oct 07, 2021
-
Nightingale to publish Financial Statements Release for financial year July 2020–June 2021 on 15 September 2021 – Sep 07, 2021
-
Reaktor becomes strategic partner of Nightingale to accelerate international growth – May 04, 2021
-
Nightingale intends to launch an initial public offering and listing on Nasdaq First North Growth Market Finland – Feb 19, 2021
-
Nightingale Health Accelerates the Availability of Its At-Home Blood Testing Solution by Launching an Early-Access Pilot for 10,000 Consumers in Finland – Feb 17, 2021
-
Nightingale Health and Estonian Biobank Agree Strategic Collaboration Aiming to Work Towards Estonian Biobank’s Nationwide Early Disease Prevention in Estonia – Feb 04, 2021
-
Nightingale to roll-out novel preventative solution for COVID-19 enabling safe returns to work post lockdowns – Jul 06, 2020
-
Nightingale Health’s blood analysis shows great promise for preventative COVID-19 and Pneumonia Risk Detection – Jun 15, 2020
-
Nightingale Health Opens EUR 50-80M Private Placement Round with Carnegie as its Advisor to Bring Nightingale’s Preventative Health Technology to International Markets – Nov 21, 2019
-
Nightingale Health Announces Strategic Partnership with Kirin and Mitsui to Bring Nightingale’s Internationally Recognised Blood-Testing Services to the Japanese Market – Nov 15, 2019
-
New technology links chronic inflammation with increased risk of a wide range of diseases and shorter lifespan – Nov 15, 2018
-
Healthcare start up Nightingale invited to solve world’s biggest health problem with the UN and MIT – Feb 17, 2017
-
Pioneering Healthcare Company changes name from Brainshake to “Nightingale Health” – Feb 17, 2017
-
Blood Analysis Company Brainshake Closes Funding of €2M Three Months after First Round – Oct 03, 2016
-
Brainshake Closes €3.5M to Advance Regulatory Approval of Blood Analysis Service – Sep 14, 2016
